Skip to main content
. 2004 Jan 26;2004(1):CD003133. doi: 10.1002/14651858.CD003133.pub2

1.

1

Forest plot of comparison: 1 Leukotriene Receptor Antagonists (LTRA) + ICS vs. same dose of ICS in SYMPTOMATIC patients, outcome: 1.2 Patients with exacerbations requiring systemic steroids with licensed AL doses at 4 to 16 weeks.